These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9709962)

  • 1. Serum high molecular weight form of insulin-like growth factor II from patients with non-islet cell tumor hypoglycemia is O-glycosylated.
    Hizuka N; Fukuda I; Takano K; Asakawa-Yasumoto K; Okubo Y; Demura H
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2875-7. PubMed ID: 9709962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing.
    Daughaday WH; Trivedi B; Baxter RC
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5823-7. PubMed ID: 7685912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor II in 44 patients with non-islet cell tumor hypoglycemia.
    Hizuka N; Fukuda I; Takano K; Okubo Y; Asakawa-Yasumoto K; Demura H
    Endocr J; 1998 Apr; 45 Suppl():S61-5. PubMed ID: 9790231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of glucose-regulatory hormones in patients with non-islet cell tumor hypoglycemia: including a review of the literature.
    Fukuda I; Asai A; Nagamine T; Harada T; Tanimura-Inagaki K; Hizuka N; Sugihara H
    Endocr J; 2017 Jul; 64(7):719-726. PubMed ID: 28529277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of a giant phyllodes tumor of the breast with hypoglycemia caused by high-molecular-weight insulin-like growth factor II.
    Hino N; Nakagawa Y; Ikushima Y; Yoshida M; Tsuyuguchi M
    Breast Cancer; 2010 Apr; 17(2):142-5. PubMed ID: 19259766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia.
    Fukuda I; Hizuka N; Ishikawa Y; Yasumoto K; Murakami Y; Sata A; Morita J; Kurimoto M; Okubo Y; Takano K
    Growth Horm IGF Res; 2006 Aug; 16(4):211-6. PubMed ID: 16860583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of proinsulin-like growth factor-II E-region immunoreactivity in serum and other biological fluids.
    Liu F; Baker BK; Powell DR; Hintz RL
    J Clin Endocrinol Metab; 1993 May; 76(5):1095-100. PubMed ID: 8496298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia.
    Frystyk J; Skjaerbaek C; Zapf J; Orskov H
    Diabetologia; 1998 May; 41(5):589-94. PubMed ID: 9628278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Column chromatographic characterization of complex formation of pro-IGF-II isoforms with acid labile subunit and IGF-binding proteins associated with non-islet cell tumour induced hypoglycaemia.
    van Veggel KM; Huits RM; Donker GH; Lentjes EG; van Doorn J
    Growth Horm IGF Res; 2014 Dec; 24(6):233-8. PubMed ID: 25174810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of insulin-like growth factor II (IGF-II) and IGF binding proteins in patients with non-islet-cell tumor hypoglycemia.
    Fukuda I; Hizuka N; Takano K; Asakawa-Yasumoto K; Shizume K; Demura H
    Endocr J; 1993 Feb; 40(1):111-9. PubMed ID: 7524924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia.
    van Doorn J; Hoogerbrugge CM; Koster JG; Bloemen RJ; Hoekman K; Mudde AH; van Buul-Offers SC
    Clin Chem; 2002 Oct; 48(10):1739-50. PubMed ID: 12324491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
    Miraki-Moud F; Grossman AB; Besser M; Monson JP; Camacho-Hübner C
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3819-23. PubMed ID: 15840753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia.
    Daughaday WH; Trivedi B
    J Clin Endocrinol Metab; 1992 Jul; 75(1):110-5. PubMed ID: 1618998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.
    Daughaday WH; Kapadia M
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6778-82. PubMed ID: 2771956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypoglycemia using combined glucocorticoid and recombinant human growth hormone in a patient with a metastatic non-islet cell tumor hypoglycemia.
    Bourcigaux N; Arnault-Ouary G; Christol R; Périn L; Charbonnel B; Le Bouc Y
    Clin Ther; 2005 Feb; 27(2):246-51. PubMed ID: 15811488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic potential of miR-483 family for IGF-II producing non-islet cell tumor hypoglycemia.
    Nagao M; Fukuda I; Asai A; Esguerra JLS; Hizuka N; Eliasson L; Sugihara H
    Eur J Endocrinol; 2021 Jan; 184(1):41-49. PubMed ID: 33112286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH).
    Teale JD; Marks V
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):491-8. PubMed ID: 9876347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe hypoglycemia with "Big"-IGF-2 oversecretion by a giant phyllode tumor of the breast: a rare case of non-islet cell tumor-induced hypoglycemia (NICTH).
    Renard E; Langbour-Remy C; Klein M; Le Bouc Y; Weryha G; Cuny T
    Ann Endocrinol (Paris); 2012 Nov; 73(5):488-91. PubMed ID: 22867750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study.
    Kawai S; Ariyasu H; Uraki S; Takeshima K; Morita S; Inaba H; Iwakura H; Doi A; Ohashi T; Kawago M; Matsuoka N; Okamura S; Tsujii S; Akamizu T
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2728-2734. PubMed ID: 29897468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of serum peptides with immunoactivity detected by a radioimmunoassay for proinsulin-like growth factor-II E domain: description of a free E domain peptide in serum.
    Daughaday WH; Trivedi B
    J Clin Endocrinol Metab; 1992 Aug; 75(2):641-5. PubMed ID: 1379260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.